ZIP kinase plays a crucial role in androgen receptor-mediated transcription

Oncogene

Volumn 27, Issue 23, 2008, Pages 3292-3300

  Leister, P ^a,b   Felten, A ^a   Chasan, A I ^a   Scheidtmann, K H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NRW ^*  (Germany)

Author keywords

AATF Che 1; Androgen receptor; Co activators; ZIP kinase DAP like kinase

Indexed keywords

ANDROGEN RECEPTOR; LUCIFERASE; PROGESTERONE RECEPTOR; PROTEIN KINASE; ZIPPER INTERACTING PROTEIN KINASE;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELLS, CULTURED; ENHANCER ELEMENTS (GENETICS); HUMANS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RATS; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 44349160256     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210995     Document Type: Article

References (36)

1. Bruno T, De Angelis R, De Nicola F, Barbato C, Di Padova M, Corbi N et al. (2002). Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb. Cancer Cell 2: 387-399.
2. Bruno T, De Nicola F, Iezzi S, Lecis D, D'Angelo C, Di Padova M et al. (2006). Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. Cancer Cell 10: 473-486.
3. Burgdorf S, Leister P, Scheidtmann KH. (2004). TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination. J Biol Chem 279: 17524-17534.
4. Chen S, Xu Y, Yuan X, Bubley GJ, Balk SP. (2006). Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1. Proc Natl Acad Sci USA 103: 15969-15974.
5. Debes JD, Tindall DJ. (2002). The role of androgens and the androgen receptor in prostate cancer. Cancer Lett 187: 1-7.
6. Di Padova M, Bruno T, De Nicola F, Iezzi S, D'Angelo C, Gallo R et al. (2003). Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoter. J Biol Chem 278: 36496-36504.
7. Engemann H, Heinzel V, Page G, Preuss U, Scheidtmann KH. (2002). DAP-like kinase interacts with the rat homolog of Schizosaccharomyces pombe CDC5 protein, a factor involved in pre-mRNA splicing and required for G2/M phase transition. Nucleic Acids Res 30: 1408-1417.
8. Fanciulli M, Bruno T, Di Padova M, De Angelis R, Iezzi S, Iacobini C et al. (2000). Identification of a novel partner of RNA polymerase II subunit 11, Che- 1, which interacts with and affects the growth suppression function of Rb. FASEB J 14: 904-912.
9. Felten A, Leister P, Burgdorf S, Uhlmann L, Scheidtmann KH. (2007). Characterization of rat BLOS2/Ceap, a putative yeast She3 homolog, as interaction partner of apoptosis antagonizing transcription factor/Che-1. Biol Chem 388: 569-582.
10. Gao S, Wang H, Lee P, Melamed J, Li CX, Zhang F et al. (2006). Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland. J Mol Endocrinol 36: 463-483.
11. Gioeli D, Ficarro SB, Kwiek JJ, Aaronson D, Hancock M, Catling AD et al. (2002). Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 277: 29304-29314.
12. Haystead TA. (2005). ZIP kinase, a key regulator of myosin protein phosphatase 1. Cell Signal 17: 1313-1322.
13. Kawai T, Akira S, Reed JC. (2003). ZIP kinase triggers apoptosis from nuclear PML oncogenic domains. Mol Cell Biol 23: 6174-6186.
14. Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S. (1998). ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol Cell Biol 18: 1642-1651.
15. Kim J, Coetzee GA. (2004). Prostate specific antigen gene regulation by androgen receptor. J Cell Biochem 93: 233-241.
16. Kögel D, Bierbaum H, Preuss U, Scheidtmann KH. (1999). C-terminal truncation of Dlk/ZIP kinase leads to abrogation of nuclear transport and high apoptotic activity. Oncogene 18: 7212-7218.
17. Kögel D, Prehn JH, Scheidtmann KH. (2001). The DAP kinase family of pro-apoptotic proteins: novel players in the apoptotic game. BioEssays 23: 352-358.
18. Leister P, Burgdorf S, Scheidtmann KH. (2003). Apoptosis antagonizing transcription factor AATF is a novel co-activator of nuclear hormone receptors. Signal Transduction 3: 17-25.
19. Lohrum M, Scheidtmann KH. (1996). Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes. Oncogene 13: 2527-2539.
20. Lonard DM, O'malley BW. (2006). The expanding cosmos of nuclear receptor coactivators. Cell 125: 411-414.
21. McEwan IJ. (2004). Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain. Endocr Relat Cancer 11: 281-293.
22. McKenna NJ, O'malley BW. (2002). Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474.
23. Muller JM, Isele U, Metzger E, Rempel A, Moser M, Pscherer A et al. (2000). FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J 19: 359-369.
24. Nelson JD, Denisenko O, Sova P, Bomsztyk K. (2006). Fast chromatin immunoprecipitation assay. Nucleic Acids Res 34: e2.
25. Otten AD, Sanders MM, McKnight GS. (1988). The MMTV LTR promoter is induced by progesterone and dihydrotestosterone but not by estrogen. Mol Endocrinol 2: 143-147.
26. Page G, Kögel D, Rangnekar V, Scheidtmann KH. (1999a). Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis. Oncogene 18: 7265-7273.
27. Page G, Lödige I, Kögel D, Scheidtmann KH. (1999b). AATF, a novel transcription factor that interacts with Dlk/ZIP kinase and interferes with apoptosis. FEBS Lett 462: 187-191.
28. Rosenfeld MG, Glass CK. (2001). Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276: 36865-36868.
29. Sato N, Kawai T, Sugiyama K, Muromoto R, Imoto S, Sekine Y et al. (2005). Physical and functional interactions between STAT3 and ZIP kinase. Int Immunol 17: 1543-1552.
30. Scheidtmann KH. (2007). Dlk/ZIP kinase, a novel Ser/Thr-specific protein kinase with multiple functions. Signal Transduction 7: 248-259.
31. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. (2000). Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852.
32. Taplin ME, Balk SP. (2004). Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 91: 483-490.
33. Thomas T, Voss AK, Petrou P, Gruss P. (2000). The murine gene, Traube, is essential for the growth of preimplantation embryos. Dev Biol 227: 324-342.
34. Ueda T, Bruchovsky N, Sadar MD. (2002). Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem 277: 7076-7085.
35. Wang Q, Carroll JS, Brown M. (2005). Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19: 631-642.
36. Wu RC, Smith CL, O'malley BW. (2005). Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr Rev 26: 393-399.